Key facts
- Cubec’s last known valuation is $2.4M (Aug 2025).
- It has raised $1.7M; the latest was Early Stage VC ($640K) in Aug 2025.
- Notable investors include ANOBAKA, FASTAR, Kyoto Capital Partners (Japan), Full Commit Partners, Kawasaki-NEDO Innovation Center — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Cubec
- ·The full record, as it builds
Funding rounds
No funding rounds for Cubec are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cubec
Developer of AI-powered clinical decision support systems designed for improving access to optimal medical care. The company's systems integrate machine learning, deep learning, and large language models to deliver diagnostic and treatment suggestions, enabling healthcare providers to navigate complex medical scenarios with enhanced precision.
- Sector
- Healthcare
- HQ
- Suita, Japan
- Founded
- 2023
- Employees
- 5
- Website
- cubec.jp/
- Ownership
- Privately Held (backing)
Cubec doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cubec shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cubec in its N-PORT filings yet. We sweep new filings monthly.